The αTSR Domain of Plasmodium Circumsporozoite Protein Bound Heparan Sulfates and Elicited High Titers of Sporozoite Binding Antibody After Displayed by Nanoparticles

References

• World Health Organization. World Malaria Report 2021. World Health Organization; 2022.
   Google Scholar
• World Health Organization. World Malaria Report 2019. World Health Organization; 2019.
   Google Scholar
• Kappe SH, Buscaglia CA, Nussenzweig V. Plasmodium sporozoite molecular cell biology. Annu Rev Cell Dev Biol. 2004;20:29–59. doi:10.1146/annurev.cellbio.20.011603.150935
   PubMed Web of Science ®Google Scholar
• Menard R. The journey of the malaria sporozoite through its hosts: two parasite proteins lead the way. Microbes Infect. 2000;2(6):633–642. doi:10.1016/S1286-4579(00)00362-2
   PubMed Web of Science ®Google Scholar
• Gosling R, von Seidlein L. The Future of the RTS, S/AS01 malaria vaccine: an alternative development plan. PLoS Med. 2016;13(4):e1001994. doi:10.1371/journal.pmed.1001994
   PubMed Web of Science ®Google Scholar
• Laurens MB. RTS, S/AS01 vaccine (Mosquirix): an overview. Hum Vaccin Immunother. 2020;16(3):480–489. doi:10.1080/21645515.2019.1669415
   PubMed Web of Science ®Google Scholar
• Prudencio M, Rodriguez A, Mota MM. The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol. 2006;4(11):849–856. doi:10.1038/nrmicro1529
   PubMed Web of Science ®Google Scholar
• Sturm A, Amino R, van de Sand C, et al. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science. 2006;313(5791):1287–1290. doi:10.1126/science.1129720
   PubMed Web of Science ®Google Scholar
• Gerald N, Mahajan B, Kumar S. Mitosis in the human malaria parasite Plasmodium falciparum. Eukaryotic Cell. 2011;10(4):474–482. doi:10.1128/EC.00314-10
   PubMedGoogle Scholar
• Josling GA, Llinas M. Sexual development in Plasmodium parasites: knowing when it’s time to commit. Nat Rev Microbiol. 2015;13(9):573–587.
   PubMed Web of Science ®Google Scholar
• Bancells C, Llora-Batlle O, Poran A, et al. Revisiting the initial steps of sexual development in the malaria parasite Plasmodium falciparum. Nat Microbiol. 2019;4(1):144–154. doi:10.1038/s41564-018-0291-7
   PubMed Web of Science ®Google Scholar
• Bennink S, Kiesow MJ, Pradel G. The development of malaria parasites in the mosquito midgut. Cell Microbiol. 2016;18(7):905–918. doi:10.1111/cmi.12604
   PubMed Web of Science ®Google Scholar
• Medica DL, Sinnis P. Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes. Infect Immun. 2005;73(7):4363–4369. doi:10.1128/IAI.73.7.4363-4369.2005
   PubMed Web of Science ®Google Scholar
• Sinnis P, Zavala F. The skin: where malaria infection and the host immune response begin. Semin Immunopathol. 2012;34(6):787–792. doi:10.1007/s00281-012-0345-5
   PubMed Web of Science ®Google Scholar
• Dundas K, Shears MJ, Sinnis P, Wright GJ. Important extracellular interactions between plasmodium sporozoites and host cells required for infection. Trends Parasitol. 2019;35(2):129–139. doi:10.1016/j.pt.2018.11.008
   PubMed Web of Science ®Google Scholar
• Doud MB, Koksal AC, Mi LZ, Song G, Lu C, Springer TA. Unexpected fold in the circumsporozoite protein target of malaria vaccines. Proc Natl Acad Sci USA. 2012;109(20):7817–7822. doi:10.1073/pnas.1205737109
   PubMed Web of Science ®Google Scholar
• Wang Q, Fujioka H, Nussenzweig V. Mutational analysis of the GPI-anchor addition sequence from the circumsporozoite protein of Plasmodium. Cell Microbiol. 2005;7(11):1616–1626. doi:10.1111/j.1462-5822.2005.00579.x
   PubMed Web of Science ®Google Scholar
• Pinzon-Ortiz C, Friedman J, Esko J, Sinnis P. The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for plasmodium sporozoite attachment to target cells. J Biol Chem. 2001;276(29):26784–26791. doi:10.1074/jbc.M104038200
   PubMed Web of Science ®Google Scholar
• Coppi A, Tewari R, Bishop JR, et al. Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe. 2007;2(5):316–327. doi:10.1016/j.chom.2007.10.002
   PubMed Web of Science ®Google Scholar
• Frevert U, Sinnis P, Cerami C, Shreffler W, Takacs B, Nussenzweig V. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J Exp Med. 1993;177(5):1287–1298. doi:10.1084/jem.177.5.1287
   PubMed Web of Science ®Google Scholar
• Cerami C, Kwakye-Berko F, Nussenzweig V. Binding of malarial circumsporozoite protein to sulfatides [Gal(3-SO4)beta 1-Cer] and cholesterol-3-sulfate and its dependence on disulfide bond formation between cysteines in region II. Mol Biochem Parasitol. 1992;54(1):1–12. doi:10.1016/0166-6851(92)90089-3
   PubMed Web of Science ®Google Scholar
• Cerami C, Frevert U, Sinnis P, et al. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell. 1992;70(6):1021–1033. doi:10.1016/0092-8674(92)90251-7
   PubMed Web of Science ®Google Scholar
• Sinnis P, Clavijo P, Fenyo D, Chait BT, Cerami C, Nussenzweig V. Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J Exp Med. 1994;180(1):297–306. doi:10.1084/jem.180.1.297
   PubMed Web of Science ®Google Scholar
• Ancsin JB, Kisilevsky R. A binding site for highly sulfated heparan sulfate is identified in the N terminus of the circumsporozoite protein: significance for malarial sporozoite attachment to hepatocytes. J Biol Chem. 2004;279(21):21824–21832. doi:10.1074/jbc.M401979200
   PubMed Web of Science ®Google Scholar
• Kumar KA, Sano G, Boscardin S, et al. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature. 2006;444(7121):937–940. doi:10.1038/nature05361
   PubMed Web of Science ®Google Scholar
• Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature. 1967;216(5111):160–162. doi:10.1038/216160a0
   PubMed Web of Science ®Google Scholar
• Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ. 1979;57(1):165–173.
   PubMedGoogle Scholar
• Clyde DF, McCarthy VC, Miller RM, Hornick RB. Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am J Med Sci. 1973;266(6):398–403. doi:10.1097/00000441-197312000-00001
   PubMed Web of Science ®Google Scholar
• Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 1989;341(6240):323–326. doi:10.1038/341323a0
   PubMed Web of Science ®Google Scholar
• Reece WH, Pinder M, Gothard PK, et al. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med. 2004;10(4):406–410. doi:10.1038/nm1009
   PubMed Web of Science ®Google Scholar
• Rts SCTP. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a Phase 3, individually randomised, controlled trial. Lancet. 2015;386(9988):31–45.
   PubMed Web of Science ®Google Scholar
• Targett G. Phase 3 trial with the RTS, S/AS01 malaria vaccine shows protection against clinical and severe malaria in infants and children in Africa. Evid Based Med. 2015;20(1):9. doi:10.1136/ebmed-2014-110089
   PubMedGoogle Scholar
• Tan M, Jiang X. Norovirus capsid protein-derived nanoparticles and polymers as versatile platforms for antigen presentation and vaccine development. Pharmaceutics. 2019;11(9). doi:10.3390/pharmaceutics11090472
   Web of Science ®Google Scholar
• Xia M, Huang P, Sun C, et al. Bioengineered norovirus S60 nanoparticles as a multifunctional vaccine platform. ACS Nano. 2018;12(11):10665–10682. doi:10.1021/acsnano.8b02776
   PubMed Web of Science ®Google Scholar
• Xia M, Hoq MR, Huang P, Jiang W, Jiang X, Tan M. Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity. Nano Res. 2022;2022:1–10.
   Google Scholar
• Cibulskis RE, Alonso P, Aponte J, et al. Malaria: global progress 2000–2015 and future challenges. Infect Dis Poverty. 2016;5(1):61. doi:10.1186/s40249-016-0151-8
   PubMedGoogle Scholar
• Tan M, Jiang X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol. 2005;79(22):14017–14030. doi:10.1128/JVI.79.22.14017-14030.2005
   PubMed Web of Science ®Google Scholar
• Tan M, Hegde RS, Jiang X. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol. 2004;78(12):6233–6242. doi:10.1128/JVI.78.12.6233-6242.2004
   PubMed Web of Science ®Google Scholar
• Wang L, Huang P, Fang H, et al. Polyvalent complexes for vaccine development. Biomaterials. 2013;34(18):4480–4492. doi:10.1016/j.biomaterials.2013.02.041
   PubMed Web of Science ®Google Scholar
• Xia M, Huang P, Jiang X, Tan M. A nanoparticle-based trivalent vaccine targeting the glycan binding VP8* domains of rotaviruses. Viruses. 2021;13(1):72. doi:10.3390/v13010072
   PubMed Web of Science ®Google Scholar
• Huang P, Farkas T, Zhong W, et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol. 2005;79(11):6714–6722. doi:10.1128/JVI.79.11.6714-6722.2005
   PubMed Web of Science ®Google Scholar
• Kimanius D, Dong L, Sharov G, Nakane T, Scheres SHW. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem J. 2021;478(24):4169–4185. doi:10.1042/BCJ20210708
   PubMed Web of Science ®Google Scholar
• Sun C, Gonzalez B, Vago FS, Jiang W. High resolution single particle Cryo-EM refinement using JSPR. Prog Biophys Mol Biol. 2021;160:37–42. doi:10.1016/j.pbiomolbio.2020.05.006
   PubMed Web of Science ®Google Scholar
• Guo F, Jiang W. Single particle cryo-electron microscopy and 3-D reconstruction of viruses. Methods Mol Biol. 2014;1117:401–443.
   PubMedGoogle Scholar
• Goddard TD, Huang CC, Ferrin TE. Visualizing density maps with UCSF Chimera. J Struct Biol. 2007;157(1):281–287. doi:10.1016/j.jsb.2006.06.010
   PubMed Web of Science ®Google Scholar
• Burmeister WP, Buisson M, Estrozi LF, et al. Structure determination of feline calicivirus virus-like particles in the context of a pseudo-octahedral arrangement. PLoS One. 2015;10(3):e0119289. doi:10.1371/journal.pone.0119289
   PubMed Web of Science ®Google Scholar
• Marty MT, Baldwin AJ, Marklund EG, Hochberg GK, Benesch JL, Robinson CV. Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles. Anal Chem. 2015;87(8):4370–4376. doi:10.1021/acs.analchem.5b00140
   PubMed Web of Science ®Google Scholar
• Kitova EN, El-Hawiet A, Schnier PD, Klassen JS. Reliable determinations of protein-ligand interactions by direct ESI-MS measurements. Are we there yet? J Am Soc Mass Spectrom. 2012;23(3):431–441. doi:10.1007/s13361-011-0311-9
   PubMed Web of Science ®Google Scholar
• Sonn-Segev A, Belacic K, Bodrug T, et al. Quantifying the heterogeneity of macromolecular machines by mass photometry. Nat Commun. 2020;11(1):1772. doi:10.1038/s41467-020-15642-w
   PubMed Web of Science ®Google Scholar
• Tan M, Huang P, Xia M, et al. Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol. 2011;85(2):753–764. doi:10.1128/JVI.01835-10
   PubMed Web of Science ®Google Scholar
• Xia M, Wei C, Wang L, et al. Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus. Sci Rep. 2016;6:25735. doi:10.1038/srep25735
   PubMed Web of Science ®Google Scholar
• Xia M, Wei C, Wang L, et al. A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus. Vaccine. 2016;34(7):905–913. doi:10.1016/j.vaccine.2015.12.068
   PubMed Web of Science ®Google Scholar
• Zhang M, Mandraju R, Rai U, Shiratsuchi T, Tsuji M. Monoclonal antibodies against plasmodium falciparum circumsporozoite protein. Antibodies. 2017;6(3). doi:10.3390/antib6030011
   Google Scholar
• Swearingen KE, Lindner SE, Shi L, et al. Interrogating the plasmodium sporozoite surface: identification of surface-exposed proteins and demonstration of glycosylation on CSP and TRAP by mass spectrometry-based proteomics. PLoS Pathog. 2016;12(4):e1005606. doi:10.1371/journal.ppat.1005606
   PubMed Web of Science ®Google Scholar
• Huang P, Xia M, Tan M, et al. Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol. 2012;86(9):4833–4843. doi:10.1128/JVI.05507-11
   PubMed Web of Science ®Google Scholar
• Liu Y, Huang P, Jiang B, Tan M, Morrow AL, Jiang X. Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants. PLoS One. 2013;8(11):e78113. doi:10.1371/journal.pone.0078113
   PubMed Web of Science ®Google Scholar
• Liu Y, Ramelot TA, Huang P, et al. Glycan specificity of P[19] rotavirus and comparison with those of related P genotypes. J Virol. 2016;90(21):9983–9996. doi:10.1128/JVI.01494-16
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu S, Woodruff AL, et al. Structural basis of glycan specificity of P[19] VP8*: implications for rotavirus zoonosis and evolution. PLoS Pathog. 2017;13(11):e1006707. doi:10.1371/journal.ppat.1006707
   PubMed Web of Science ®Google Scholar
• Tan M, Jiang X. Recent advancements in combination subunit vaccine development. Hum Vaccin Immunother. 2017;13(1):180–185. doi:10.1080/21645515.2016.1229719
   PubMed Web of Science ®Google Scholar
• Tan M, Jiang X. Nanoparticles of Norovirus. In: Khudyakov Y, Pumpens P, editors. Viral Nanotechnology. Norwich, UK: CRC Press, Taylor &Francis Group; 2015:363–371.
   Google Scholar
• Tan M, Jiang X. Subviral particle as vaccine and vaccine platform. Curr Opin Virol. 2014;6:24–33. doi:10.1016/j.coviro.2014.02.009
   PubMed Web of Science ®Google Scholar
• Liu C, Huang P, Zhao D, et al. Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine. Vaccine. 2020;2020:1.
   Google Scholar
• Xu S, Ahmed LU, Stuckert MR, et al. Molecular basis of P[II] major human rotavirus VP8* domain recognition of histo-blood group antigens. PLoS Pathog. 2020;16(3):e1008386. doi:10.1371/journal.ppat.1008386
   PubMed Web of Science ®Google Scholar
• Xu S, McGinnis KR, Liu Y, et al. Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens. Proc Natl Acad Sci USA. 2021;118:36.
   Web of Science ®Google Scholar
• Xia M, Huang P, Jiang X, Tan M. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice. Vaccine. 2019;37(30):4103–4110. doi:10.1016/j.vaccine.2019.05.075
   PubMed Web of Science ®Google Scholar
• Xia M, Huang P, Tan M. A pseudovirus nanoparticle-based trivalent rotavirus vaccine candidate elicits high and cross P type immune response. Pharmaceutics. 2022;14(8):1597. doi:10.3390/pharmaceutics14081597
   PubMed Web of Science ®Google Scholar